BACKGROUND: Carotid-femoral pulse wave velocity (CFPWV) is a heritable measure of aortic stiffness that is strongly associated with increased risk for major cardiovascular disease events. METHODS AND RESULTS: We conducted a meta-analysis of genome-wide association data in 9 community-based European ancestry cohorts consisting of 20 634 participants. Results were replicated in 2 additional European ancestry cohorts involving 5306 participants. Based on a preliminary analysis of 6 cohorts, we identified a locus on chromosome 14 in the 3'-BCL11B gene desert that is associated with CFPWV (rs7152623, minor allele frequency=0.42, β=-0.075±0.012 SD/allele, P=2.8×10(-10); replication β=-0.086±0.020 SD/allele, P=1.4×10(-6)). Combined results for rs7152623 from 11 cohorts gave β=-0.076±0.010 SD/allele, P=3.1×10(-15). The association persisted when adjusted for mean arterial pressure (β=-0.060±0.009 SD/allele, P=1.0×10(-11)). Results were consistent in younger (<55 years, 6 cohorts, n=13 914, β=-0.081±0.014 SD/allele, P=2.3×10(-9)) and older (9 cohorts, n=12 026, β=-0.061±0.014 SD/allele, P=9.4×10(-6)) participants. In separate meta-analyses, the locus was associated with increased risk for coronary artery disease (hazard ratio=1.05; confidence interval=1.02-1.08; P=0.0013) and heart failure (hazard ratio=1.10, CI=1.03-1.16, P=0.004). CONCLUSIONS: Common genetic variation in a locus in the BCL11B gene desert that is thought to harbor 1 or more gene enhancers is associated with higher CFPWV and increased risk for cardiovascular disease. Elucidation of the role this novel locus plays in aortic stiffness may facilitate development of therapeutic interventions that limit aortic stiffening and related cardiovascular disease events.
BACKGROUND: Carotid-femoral pulse wave velocity (CFPWV) is a heritable measure of aortic stiffness that is strongly associated with increased risk for major cardiovascular disease events. METHODS AND RESULTS: We conducted a meta-analysis of genome-wide association data in 9 community-based European ancestry cohorts consisting of 20 634 participants. Results were replicated in 2 additional European ancestry cohorts involving 5306 participants. Based on a preliminary analysis of 6 cohorts, we identified a locus on chromosome 14 in the 3'-BCL11B gene desert that is associated with CFPWV (rs7152623, minor allele frequency=0.42, β=-0.075±0.012 SD/allele, P=2.8×10(-10); replication β=-0.086±0.020 SD/allele, P=1.4×10(-6)). Combined results for rs7152623 from 11 cohorts gave β=-0.076±0.010 SD/allele, P=3.1×10(-15). The association persisted when adjusted for mean arterial pressure (β=-0.060±0.009 SD/allele, P=1.0×10(-11)). Results were consistent in younger (<55 years, 6 cohorts, n=13 914, β=-0.081±0.014 SD/allele, P=2.3×10(-9)) and older (9 cohorts, n=12 026, β=-0.061±0.014 SD/allele, P=9.4×10(-6)) participants. In separate meta-analyses, the locus was associated with increased risk for coronary artery disease (hazard ratio=1.05; confidence interval=1.02-1.08; P=0.0013) and heart failure (hazard ratio=1.10, CI=1.03-1.16, P=0.004). CONCLUSIONS: Common genetic variation in a locus in the BCL11B gene desert that is thought to harbor 1 or more gene enhancers is associated with higher CFPWV and increased risk for cardiovascular disease. Elucidation of the role this novel locus plays in aortic stiffness may facilitate development of therapeutic interventions that limit aortic stiffening and related cardiovascular disease events.
Authors: E J Balkestein; J A Staessen; J G Wang; J J van Der Heijden-Spek; L M Van Bortel; C Barlassina; G Bianchi; E Brand; S M Herrmann; H A Struijker-Boudier Journal: Hypertension Date: 2001-11 Impact factor: 10.190
Authors: S Laurent; P Boutouyrie; R Asmar; I Gautier; B Laloux; L Guize; P Ducimetiere; A Benetos Journal: Hypertension Date: 2001-05 Impact factor: 10.190
Authors: Ulrich Broeckel; Christian Hengstenberg; Björn Mayer; Stephan Holmer; Lisa J Martin; Anthony G Comuzzie; John Blangero; Peter Nürnberg; André Reis; Günter A J Riegger; Howard J Jacob; Heribert Schunkert Journal: Nat Genet Date: 2002-01-30 Impact factor: 38.330
Authors: M Lajemi; S Gautier; O Poirier; J P Baguet; A Mimran; P Gosse; O Hanon; C Labat; F Cambien; A Benetos Journal: Am J Hypertens Date: 2001-08 Impact factor: 2.689
Authors: Tanya L Medley; Timothy J Cole; Christoph D Gatzka; William Y S Wang; Anthony M Dart; Bronwyn A Kingwell Journal: Circulation Date: 2002-02-19 Impact factor: 29.690
Authors: Peter M Nilsson; Stephane Laurent; Pedro G Cunha; Michael H Olsen; Ernst Rietzschel; Oscar H Franco; Ligita Ryliškytė; Irina Strazhesko; Charalambos Vlachopoulos; Chen-Huan Chen; Pierre Boutouyrie; Francesco Cucca; Edward G Lakatta; Angelo Scuteri Journal: J Hypertens Date: 2018-12 Impact factor: 4.844
Authors: Young S Oh; Dan E Berkowitz; Richard A Cohen; C Alberto Figueroa; David G Harrison; Jay D Humphrey; Douglas F Larson; Jane A Leopold; Robert P Mecham; Nelson Ruiz-Opazo; Lakshmi Santhanam; Francesca Seta; John Y J Shyy; Zhongjie Sun; Philip S Tsao; Jessica E Wagenseil; Zorina S Galis Journal: Circ Res Date: 2017-11-10 Impact factor: 17.367
Authors: Hassan A Chami; Ramachandran S Vasan; Martin G Larson; Emelia J Benjamin; Gary F Mitchell; Daniel J Gottlieb Journal: Sleep Med Date: 2015-11-27 Impact factor: 3.492
Authors: Charlotte Andersson; Rene Quiroz; Danielle Enserro; Martin G Larson; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Emelia J Benjamin; Gary F Mitchell; Ramachandran S Vasan Journal: Hypertension Date: 2016-07-25 Impact factor: 10.190
Authors: Matthias Olden; Alexander Teumer; Murielle Bochud; Cristian Pattaro; Anna Köttgen; Stephen T Turner; Rainer Rettig; Ming-Huei Chen; Abbas Dehghan; Francois Bastardot; Reinhold Schmidt; Peter Vollenweider; Heribert Schunkert; Muredach P Reilly; Myriam Fornage; Lenore J Launer; Germaine C Verwoert; Gary F Mitchell; Joshua C Bis; Christopher J O'Donnell; Ching-Yu Cheng; Xueling Sim; David S Siscovick; Josef Coresh; W H Linda Kao; Caroline S Fox; Conall M O'Seaghdha Journal: Am J Kidney Dis Date: 2013-03-06 Impact factor: 8.860